Our previous data demonstrated that Ras activation is necessary and sucient for transforming growth factor b (TGFb)-mediated Erk1 activation, and is partially required for the inhibition of cyclin-dependent kinase 2 (Cdk2) activity, cyclin A expression and DNA synthesis by TGFb (KM Mulder and SL Morris,
Introduction
Transforming growth factor b (TGFb) is an endogenous cytokine that has multiple biological functions, including regulation of early embryonic development, induction of extracellular-matrix protein synthesis, and regulation of cell proliferation and dierentiation (Hartsough and Mulder, 1997) . The signaling receptors for TGFb (R I and R II ) are expressed at the cell surface; they are activated when they form a heteromeric complex and are phosphorylated at Ser/ Thr residues (Derynck, 1994; MassagueÂ , 1996; Feng and Deynck, 1996) . Although TGFb receptor-interacting proteins have been cloned, the role of most of these proteins in mediating biological responses of TGFb has not been elucidated (Wang et al., 1996a,b; Chen et al., 1995) . In contrast, a novel family of signaling proteins, the Smad's (Sma and Mad homologues), have recently been identi®ed and appear to play a role in TGFb signal transduction (Hartsough and Mulder, 1997; MassagueÂ , 1996; Derynck and Zhang, 1996; Wrana and Attisano, 1996) . However, our understanding of TGFb signaling pathways is still incomplete.
In addition to its role in a number of physiological processes, TGFb is a potent growth inhibitor for epithelial cells and some carcinoma cells (Hartsough and Mulder, 1997) . It arrests epithelial cells in the G 1 phase of the cell cycle by regulating G 1 cyclindependent kinases (Cdks), such as Cdk2-cyclin A/E and Cdk4/6-cyclin D (Derynck, 1994; Slingerland et al., 1994; Geng et al., 1993; Ewen et al., 1993) . These Cdks are, in turn, regulated by events which include cyclin concentration and interaction, Cdk activating kinase activity, Cdc25 phosphatase activity, and the concentration and interaction of the Cdk inhibitors (CKI's) (Morgan, 1995; Sherr and Robert, 1995) . There are two families of CKI's: Ink4 (p15, p16, p18 and p19) and Kip/Cip (p21 Cip1 , p27
Kip1 and p57 Kip2 ) (Sherr and Robert, 1995) . The growth inhibitory eect of TGFb has been associated with up-regulation of the expression levels of the Cdk inhibitors p15 Ink4 , p21 Cip1 , and p27
Kip1 (Reynisdottir et al., 1995; Elbendary et al., 1994; Florenes et al., 1996; Malliri et al., 1996; Sgambato et al., 1997; Datto et al., 1995; Li et al., 1995; Reynisdottir and MassagueÂ , 1997) .
Previously, a model was proposed to explain the cell cycle events leading to TGFb-mediated growth inhibition in proliferating cultures of mink lung epithelial (MvLu1) cells (Reynisdottir et al., 1995) . According to this model, up-regulation of p15
Ink4 by TGFb resulted in the release of p27
Kip1 from Cdk4/6 complexes, with a corresponding increase in free p27 Kip1 present in Cdk2-cyclin E complexes. The dierent subcellular locations of p15 Ink4 (cytoplasm) and p27
Kip1
(nuclear) permit p15 Ink4 and p27 Kip1 to coordinately inhibit Cdk2 and Cdk4 kinase activities (Reynisdottir et al., 1995; Reynisdottir and MassagueÂ , 1997) . This model is not universal, however, in that many cell types, including intestinal epithelial cells (IECs), do not display a TGFb-mediated increase in p15
Ink4
. In the absence of the up-regulation of p15
Ink4 by TGFb, regulation of Cdc25, p27
Kip1 , and p21 Cip1 by TGFb appear to play a more dominant role in the regulation of Cdk activity (Florenes et al., 1996; Malliri et al., 1996; Iavarone and MassagueÂ , 1997) . In this regard, a TGFbmediated alteration in Cdc25 activity has, thus far, only been observed in one cell line (Iavarone and MassagueÂ , 1997). In contrast, regulation of p21 Cip1 and p27 Kip1 by TGFb appear to be more universal (Hartsough and Mulder, 1997; Derynck, 1994) . At low concentrations, p21
Cip1 generally acts as an assembly factor to promote formation of active Cdk complexes, while at high concentrations, p21
Cip1 inhibits Cdk kinase activity; association of p27 Kip1 with Cdk complexes generally inhibits Cdk activity (LaBaer et al., 1997) . Thus, the expression levels of the Cip/Kip CKI's and their ability to associate with G 1 Cdk complexes would be expected to be important determinants in TGFb-mediated Cdk inhibition (Hartsough and Mulder, 1997; Derynck, 1994; LaBaer et al., 1997) .
Previously, we reported that stable transfection of untransformed IEC's with an inducible dominantnegative mutant of Ras (RasN17) resulted in a partial reversal of the ability of TGFb to decrease Cdk2 activity, cyclin A protein expression, and DNA synthesis (Hartsough et al., 1996) . These results demonstrate that Ras is partially required for TGFb eects on these cell cycle components. Here we demonstrate that Ras is necessary and sucient for the regulation of both p21
Cip1 and p27 Kip1 by TGFb in untransformed epithelial cells. Since a TGFb-mediated increase in Cdk-associated p15
Ink4 was not observed in this cell system, our results also suggest that p21
Cip1 and p27
Kip1 are upstream mediators of the inhibition of Cdk2 activity by TGFb. Collectively, our results demonstrate that the activation of the Ras/MAPK pathway by TGFb directly regulates the Cip/Kip CKI family which, in turn, decreases Cdk2 activity.
Results
Kinetics for TGFb 3 eects on Cdk2-associated histone H1 kinase activity and DNA synthesis in asynchronous IEC 4-1 cells Our previous data have demonstrated that TGFb is a potent growth inhibitor of exponentially proliferating cultures of IEC 4-1 cells (Mulder and Morris, 1992; Hartsough and Mulder, 1995; Mulder et al., 1993) . Here we examined the kinetics for TGFb 3 eects on Cdk2-associated histone H1 kinase activity in IEC 4-1 cells. As Figure 1a indicates, TGFb 3 resulted in a timedependent decrease in Cdk2 activity. Cdk2 activity decreased to 25% by 2 h after TGFb 3 addition, and was inhibited by 48% within 6 h of treatment. The eect in IEC 4-1 cells depicted here is similar to that in MvLu1 cells, but more rapid than that observed in proliferating cultures of keratinocytes (Reynisdottir et al., 1995) , demonstrating that cell-type dierences do exist. In addition, TGFb 3 resulted in a 60% inhibition of [ 3 H]thymidine incorporation into DNA in IEC 4-1 cells after 8 h of TGFb 3 treatment; the level of inhibition was maximal (97% inhibition) at 24 h after TGFb treatment (Figure 1b) . Thus, the eect of TGFb 3 on Cdk2 activity in IEC 4-1 cells preceded the eect of TGFb 3 on DNA synthesis.
TGFb 3 up-regulation of p21
Cip1 protein expression and Cdk2-associated p21
Cip1 in TGFb-sensitive IEC 4-1 cells
In order to determine the mechanism for the inhibition of Cdk2 activity by TGFb in IEC 4-1 cells, we examined which upstream regulators of Cdk2 might be aected by TGFb. The Cdk inhibitor p21 Cip1 is a universal CKI, which functions in the G 1 phase of the cell cycle and preferentially binds to Cdk2 (Harper et al., 1993; Luo et al., 1995) . The kinetics for TGFb 3 eects on the total cellular levels of p21
Cip1 in TGFbsensitive IEC 4-1 cells were examined by Western blot analysis, as shown in Figure 2a . the signi®cance of this decline is currently unclear. The expression levels of p21
Cip1 protein returned to the initial baseline values by 24 h after TGFb 3 addition. No TGFb regulation of p21
Cip1 could be detected in the TGFb-resistant IEC 4-6 cells (data not shown).
In order to determine whether the increase in total cell levels of p21
Cip1 led to an increase in the association of p21
Cip1 with Cdk2, the levels of Cdk2-associated p21
Cip1 were determined by sequential immunoprecipitation/immunoblot analysis, as described in Materials and methods. The data in Figure 2b indicate that p21
Cip1 association with Cdk2 increased after 2 h of TGFb addition, and reached a maximal level of 3.6-fold above initial baseline values by 4 h after TGFb treatment. Thereafter, Cdk2-associated p21
Cip1 levels declined and returned to initial baseline values by 8 h after TGFb treatment. By probing the same blot with an anti-Cdk2 antibody, the results indicated that Cdk2 levels were maintained (data not shown). Thus, the upregulation of p21 Cip1 protein expression by TGFb paralleled the TGFb-mediated increase in Cdk2 association with p21
Cip1
. Further, the kinetics for these eects suggest that these events may, at least partially, account for the decrease in Cdk2 activity.
TGFb 3 up-regulation of p27
Kip1 protein expression in asynchronous cultures of IEC 4-1 cells
Kip1 , primarily functions in the G 1 phase of the cell cycle by binding to Cdk2-cyclin E/A complexes to inhibit Cdk2 kinase activity (Toyoshima and Hunter, 1994; Polyak et al., 1994) . Thus, it was of interest to examine the eects of TGFb on total cellular protein levels of p27
Kip1 in IEC 4-1 cells as well. We stripped the same immunoblot that was probed with the anti-p21
Cip1 antibody, and probed it with an anti-p27
Kip1 antibody. As shown in Figure 3a , after 12 h of TGFb 3 treatment, p27
Kip1 levels were increased to 2.2-fold above initial baseline values. After this time, p27
Kip1 expression levels increased in a time-dependent fashion, reaching levels 8.2-fold above initial baseline values by 24 h. In contrast, basal p27
Kip1 expression levels in the absence of TGFb 3 were increased by only twofold above initial baseline values after 24 h (indicated by 0 24 in Figure 3a ). These results indicate that the dramatic increase in the total cellular levels of p27
Kip1 was due speci®cally to TGFb 3 treatment, and not to serum deprivation.
As shown in Figure 3b , similar experiments were performed with the TGFb-resistant IEC 4-6 cells (Mulder et al., 1993) . In contrast to the TGFb 3 upregulation of p27
Kip1 protein expression observed in the TGFb-sensitive IEC 4-1 cells, p27
Kip1 expression levels were similar in the TGFb 3 -treated and untreated control 4-6 cells. In both groups of cells, p27
Kip1 levels were twofold above initial baseline values after 24 h. Thus, the TGFb-mediated increase in p27
Kip1 levels was related to the TGFb growth inhibitory responsiveness of the cells.
Kinetics for TGFb 3 eects on new synthesis of p27
Kip1 and on the association of Cdk2 with p27
Kip1
The increase of total cellular p27 Kip1 protein levels in the TGFb-sensitive IEC 4-1 cells was not observed until 12 h after TGFb addition, at a time after the decline in Cdk2 activity and DNA synthesis had already begun. These results suggest that the increase in total cell levels of p27
Kip1 do not mediate the decrease in Cdk2 activity and DNA synthesis, but occur in association with these events. Thus, we examined the kinetics for TGFb eects on p27 Cip1 in TGFb-sensitive IEC 4-1. Proliferating cultures of IEC 4-1 cells were incubated in serum-free medium in the absence or presence of TGFb 3 (10 ng/ ml) for the indicated tissues. (a) Total cell lysates were subjected to immunoblot analysis with an anti-p21
Cip1 antibody. The closed circle plotted at the 24 h time point indicates basal p21
Cip1 levels in the absence of TGFb after 24 h (0 24 ). (b) Total cell lysates were subjected to immunoprecipitation with anti-Cdk2 or mouse IgG, followed by SDS ± PAGE and immunoblot analysis with antip21
Cip1
. No bands at the 21 kD position were observed in nonspeci®c IgG control lanes. Bottom panels: Plots of densitometric scans of results shown in top panels. Results were representative of three independent experiments addition. Thereafter, p27
Kip1 synthesis declined. Moreover, no change in p27 Kip1 protein turnover was observed after a 4 h treatment with TGFb (data not shown). Thus, the TGFb-mediated increase in newly synthesized p27
Kip1 may facilitate the interaction of this CKI with Cdk2. Although the changes observed here are only on the order of 2 ± 3-fold, localized alterations in cell cycle components of this magnitude have been shown to be functionally signi®cant (Florenes et al., 1996) .
In order to determine whether the TGFb-mediated increase in new synthesis of p27
Kip1 in IEC 4-1 cells was paralleled by an increase in the association of p27 Kip1 with Cdk2, sequential immunoprecipitation/immunoblot analyses were performed using anti-Cdk2 as the immunoprecipitating antibody and anti-p27
Kip1 as the immunoblotting antibody, as described in Materials and methods. As shown in Figure 4b Proliferating cultures of IEC 4-1 cells were incubated in methionine-free RPMI and were treated with TGFb 3 (10 ng/ml) for the indicated times, followed by 35 S-methionine labeling for the last 4 h of the treatment period. Samples were normalized for radioactivity as determined by TCA precipitation. Labeled proteins were immunoprecipitated with anti-p27
Kip1 or rabbit IgG, and were analysed by SDS ± PAGE and autoradiography. (b) Proliferating cultures of IEC 4-1 cells were incubated in serumfree medium in the presence or absence of TGFb 3 (10 ng/ml) for the indicated times. Total cell lysates were immunoprecipitated with either IgG or an anti-Cdk2 antibody. The immunocomplexes were resolved by SDS ± PAGE, and subjected to immunoblot analysis with an anti-p27
Kip1 antibody. (a) and (b) bottom panels: Plots of densitometric scans of results shown in top panels. Results are representative of three independent experiments. No bands were observed at the 27 KD position in non-speci®c IgG control lanes associated with Cdk2 in both the absence and presence of TGFb 3 . However, after 4 h of TGFb 3 treatment, the association of p27
Kip1 with Cdk2 was increased by 2.3-fold above the initial baseline values. By 6 h after TGFb treatment, p27 Kip1 in Cdk2 complexes had declined. By probing the same blot with an anti-Cdk2 antibody, we observed that Cdk2 levels were constant in Cdk2-p27
Kip1 complexes (data not shown). Thus, the results in Figure 4a and b suggest that these factors are more relevant to the regulation of Cdk2 activity by TGFb than the increase in total cellular levels of p27 Kip1 .
Eect of induction of RasN17 expression on TGFb 3 up-regulation of p21
Cip1 protein expression
Our previous data indicated that growth inhibition of IEC 4-1 cells by TGFb was associated with a rapid activation of Ras and Erk1, and that Ras was partially required for the eects of TGFb on Cdk2 activity and cyclin A protein expression (Mulder and Morris, 1992; Hartsough and Mulder, 1995; Frey and Mulder, 1997a,b; Hartsough et al., 1996) . Since p21 and p27 appear to function upstream of Cdk2, it might be expected that inactivation of Ras would block TGFb regulation of these components. Thus, we examined whether Ras activation was required for the upregulation of these CKI's by TGFb. For these studies, we utilized IEC 4-1 clones (E3, C5 and C6) which had been stably transfected with a dominantnegative mutant of Ras (RasN17) under the control of an inducible metallothionein promoter (Hartsough et al., 1996) . IEC 4-1 cells transfected with the empty vector (M2N) were used as controls. E3, C5, and M2N cells were cultured in the presence or absence of ZnCl 2 for 36 h to induce RasN17 expression, and were subsequently treated with TGFb 3 . For all studies, RasN17 expression was induced by ZnCl 2 to levels 5 ± 6-fold above initial baseline levels; these levels have previously been shown to result in a 40 ± 50% blockade of EGF+insulin+transferrin-induced Ras activation (Hartsough et al., 1996) . Figure 5a depicts the kinetics for TGFb 3 eects on total cellular levels of p21
Cip1 protein, as examined by Western blot analysis. As indicated, in the absence of ZnCl 2 , p21
Cip1 levels in E3 cells increased to 2.8-fold above initial baseline values after 6 h of TGFb 3 treatment, and then declined to baseline values by 24 h after TGFb 3 addition. These kinetics are consistent with those obtained for the IEC 4-1 cells (Figure 2a) . However, in the presence of ZnCl 2 , no TGFb-dependent increase in p21
Cip1 levels was observed in the E3 cells. Similar results were observed in the C5 clone. In contrast to the E3 and C5 cells, in the M2N control cells (depicted in Figure 5b ), TGFb 3 increased p21 Cip1 protein expression levels at very early time points, as observed for the IEC 4-1 cells. This eect occurred in both the presence and absence of ZnCl 2 . Thereafter, the p21 Cip1 levels returned to baseline values. The Ras protein levels in M2N cells did not change after ZnCl 2 treatment (data not shown).
Taken together, our data demonstrate that Ras activation is required for TGFb up-regulation of p21 Cip1 protein expression. Since the up-regulation of p21 Cip1 was completely abrogated when Ras activation was blocked, our results indicate, further, that Rasindependent pathways are not necessary for the upregulation of p21
Cip1 by TGFb, at least in this system.
Eect of RasN17 expression on the TGFb 3 up-regulation of p27 Kip1 protein expression
In order to examine whether Ras activation was also required for TGFb 3 up-regulation of the CKI p27 Kip1 , we stripped the immunoblots probed with the antip21
Cip1 antibody, and then probed them with the antip27
Kip1 antibody. As shown in Figure 6a , in the absence of ZnCl 2 , after a 24 h treatment of E3 cells with TGFb 3 , p27
Kip1 protein expression levels rose to levels sevenfold above initial baseline values; however, in the presence of ZnCl 2 , total cellular levels of p27
Kip1 in E3 cells remained at baseline values. Similar results were observed for the C5 clone. In contrast, as shown in Figure 6b , p27
Kip1 protein levels in M2N control cells a b Figure 5 Eect of induction of RasN17 on TGFb 3 up-regulation of p21 Cip1 protein expression. Proliferating cultures of N17E3 cells (a) and M2N control cells (b) were incubated in serum-free medium with or without ZnCl 2 (100 mM) for 36 h to induce RasN17 expression. Thereafter, cells were treated with or without TGFb 3 (10 ng/ml) for the indicated times. Top panels: Total cell lysates were subjected to immunoblot analysis with an antip21 Cip1 antibody. Bottom panels: Plots of densitometric scans of results shown in top panels. Results are representative of three independent experiments. Similar results were also observed for the N17C5 clone were increased by 4 ± 5-fold after 24 h of TGFb 3 treatment in both the absence and presence of ZnCl 2 . Thus, the M2N control cells were essentially unaected by ZnCl 2 treatment. These results indicate that Ras activation is also necessary and sucient for the upregulation of p27
Kip1 by TGFb.
Eect of RasN17 expression on the TGFb 3 -mediated increase in new synthesis of p27
Kip2
Since the TGFb-mediated increase in new synthesis of p27 Kip1 was temporally associated with the increased association of p27
Kip1 with Cdk2, it was of interest to determine whether Ras activation was also required for the eect of TGFb on new synthesis of p27 Kip1 . As shown in Figure 7 , in the absence of ZnCl 2 , p27 Kip1 synthesis in E3 cells increased to maximal levels of 2.8-fold above initial baseline values after 4 h of TGFb treatment. Thereafter, p27
Kip1 synthesis declined. These kinetics are consistent with those observed in the IEC 4-1 cells (Figure 4a ). However, in the presence of ZnCl 2 , the levels of p27
Kip1 synthesis were not aected by TGFb. Taken together, these data indicate that Ras activation is also required for TGFb up-regulation of p27
Kip1 synthesis.
Discussion
Here we demonstrate that Ras activation is both necessary and sucient for TGFb up-regulation of the CKI's p21 Cip1 and p27 Kip1 in proliferating cultures of untransformed epithelial cells. Moreover, the kinetics for the TGFb-mediated up-regulation of both p21 Cip1 protein expression levels and newly synthesized p27 Kip1 , as well as of the association of both CKI's with Cdk2, indicate that these events precede the decrease in Cdk2 activity after TGFb treatment. Thus, our data support a model in which p21
Cip1 and p27 Kip1 are upstream eectors of the TGFb-mediated inhibition of Cdk2 activity in untransformed epithelial cells. Further, the regulation of these CKI's requires Ras activation by TGFb.
As mentioned above, our results demonstrate that Ras is required for TGFb up-regulation of p21
Kip1
. Moreover, the initial baseline levels of both p21
Cip1 and p27 Kip1 were not aected by expression of RasN17 after the 36 h period of ZnCl 2 induction prior to TGFb addition (0 time points in Figures 5a, 6a and  7) . Thus, the inability of TGFb to increase the expression levels of these CKI's upon RasN17 induction was not the result of a generalized depletion of Ras activity leading to a cellular depletion of the CKI's. Instead, our data demonstrate that RasN17 speci®cally blocked the ability of TGFb to up-regulate the CKI's. A signi®cant role for activation of the Ras pathway in the signaling of TGFb responses is further supported by our previous reports, which have indicated that Ras and MAPKs are activated in several other epithelial cell types, but not in cells which are not growth inhibited by TGFb. The lack of growth inhibitory eect was true whether the TGFb resistance was due to a lack of TGFb receptors or to de®ciencies in postreceptor signaling events (Mulder and Morris, 1992; Hartsough and Mulder, 1995; Frey and Mulder, 1997a,b; Mulder et al., 1993) . Our previous data also demonstrated that Ras was involved in the TGFbmediated inhibition of Cdk2 activity, cyclin A expression, and cell growth (Hartsough et al., 1996) . In contrast, here we demonstrated that Ras plays a more direct role in the regulation of p21 Cip1 and p27 Kip1 by TGFb. However, requirements for other TGFb signaling components in mediating the ®nal Cdk inhibitory outcome would be expected.
The regulation of Cdk2 inhibitors by the Ras/Raf/ MAPK pathway in association with growth inhibition has been observed in other systems as well. For example, Pumiglia and Decker reported that nerve growth factor up-regulated p21
Cip1 through the activation of MAP and ERK kinase (MEK) and MAPK, ultimately inhibiting Cdk2 and Cdk4 activities in NIH3T3 cells expressing human trkA. They also demonstrated that activation of the MEK/MAPK pathway by expression of Raf-1 : ER, an inducible activated form of Raf-1, resulted in an induction of p21
Cip1 expression and an inhibition of cell growth and Cdk2 activity (Pumiglia and Decker, 1997) . Similarly, Lloyd and coworkers found that in rat Schwann cells, activation of Raf by expression of Raf-1 : ER induced p21
Cip1 expression, inhibited Cdk2 activity, and arrested cells in the G 1 phase of the cell cycle. In contrast, Raf activation in the presence of SV40 large T (LT) resulted in an increase in Cdk2-cyclin A activity and a stimulation of cell growth, while p21
Cip1 levels were not induced (Lloyd et al., 1997) . Thus, depending upon which upstream signal is received, Ras/MAPK activation may regulate dierent cell cycle events to promote opposite outcomes, stimulation or inhibition of cell growth. Our results demonstrate that TGFb activates the growth inhibitory function of the Ras/Raf/MAPK pathway in untransformed epithelial cells.
Collectively, our results are consistent with a model whereby TGFb activates Ras and Erks, possibly through Raf activation. Ras is activated prior to the up-regulation of p21
, and is required for the induction of these CKIs. Although p15
Ink association with the relevant Cdks does not appear to play a role in our system, TGFb regulation of components other than a p21
Cip1 and p27 Kip1 CKIs are presumably required to regulate the overall Cdk2 inhibitory function of the Ras pathway. In addition, other signaling pathways may also participate in mediating the Cdk inhibitory eects of TGFb (i.e., Smads, novel intermediates) (Hartsough and Mulder, 1997; MassagueÂ , 1996; Derynck and Zhang, 1996; Wrana and Attisano, 1996) . Hence, the overall biological significance of the activation of the Ras/MAPKs pathway by TGFb in epithelial cells may be to up-regulate the Cip/ Kip CKIs, thereby contributing to the assembly and inhibition of Cdk2 complexes required for the growth inhibitory and other eects of TGFb.
Materials and methods

Materials
Insulin, glucose, ATP, protein A-sepharose and protease inhibitors were purchased from Sigma (St Louis, MI). Calf thymus histone H1 was purchased from Calbiochem (La Jolla, CA). Antibodies prepared against Cdk2 (UBI #06-148 and sc-163), p27
Kip1 (sc-528), and p21 Cip1 (sc-471 and sc-397) were purchased from Santa Cruz Corp. (Santa Cruz, CA) and Upstate Biotechnology (Lake Placid, NY). Rabbit IgG (whole molecule) was purchased from Jackson ImmunoResearch (Bar Harbor, ME). TGFb 3 was a generous gift from M Morin (P®zer Pharmaceuticals, Groton, CT). [g-32 P]ATP (3000 Ci/mmol, BLU002H) and [
3 H]thymidine (20 Ci/mmol, NET027X) were purchased from DuPont NEN (Boston, MA). Geneticin (G418) was purchased from Life Technologies, Inc (Gaithersburg, MD).
Cell culture
Untransformed rat intestinal epithelial cell (IEC) lines 4-1 and 4-6 have been described previously (Mulder and Morris, 1992; Hartsough and Mulder, 1995; Mulder et al., 1993) . Cells were routinely maintained in SMIGS medium, consisting of McCoy's 5A (Life Technology, Inc.) supplemented with amino acids, pyruvate, and antibiotics (streptomycin, penicillin), and containing insulin (4 mg/ml), glucose (4.5 mg/ml) and 5% fetal bovine serum. RasN17-transfected IEC 4-1 clones (E3 and C5), and empty vectortransfected IEC 4-1 cells (M2N), isolated and characterized as described previously (Hartsough et al., 1996) , were routinely maintained in SMIGS plus G418 (131 mg/ml). The TGFb 3 isoform was utilized for the experiments described herein, since our supply of this isoform was more plentiful and we have previously shown that similar eects are generally observed with the dierent isoforms (Mulder and Morris, 1992; Hartsough and Mulder, 1995; Hartsough et al., 1996; Frey and Mulder, 1997a,b) . In addition, the TGFb isoforms resulted in similar levels of growth inhibition in IEC 4-1 cells over the concentrations 2 ± 10 ng/ml (Mulder et al., 1993; unpublished data) .
Thymidine incorporation
IEC 4-1 cells were plated at a density of 5300 cells/cm 2 in 12-well plates in SMIGS medium. The next day, cells were rinsed twice with basal medium (SM) without serum, and incubated with SM for 13 h to remove medium and cellassociated serum components. This treatment does not render the cells quiescent (Mulder and Morris, 1992) . All of our studies involving TGFb eects on cell cycle were performed in exponentially proliferating cultures of IEC cells in the absence of other growth factors. This procedure is necessary if the eect of TGFb alone (i.e., in the absence of serum or other growth factors) is to be investigated (Hartsough and Mulder, 1995) . TGFb 3 (2 ng/ml) was then added to the serum-free, asynchronous cultures for the indicated times, followed by [ 3 H]thymidine (25 mCi, 20 Ci/ mmol, NEN) addition to the cells for the last hour of the TGFb 3 treatment period. Incorporation of [ 3 H]thymidine into DNA was determined as described previously (Hartsough and Mulder, 1995) .
In vitro Cdk2 histone H1 kinase assay IEC 4-1 cells were plated and treated as described for the thymidine assay. Histone H1 kinase activity was assayed in Cdk2 immune complexes isolated from cells treated with TGFb 3 (2 ng/ml) for the indicated times. Cell lysates and immunoprecipitations were performed as described by Ewen et al. (1993) , except that lysates were precleared with protein A-sepharose for 30 min at 48C. Total cell lysates (240 mg per sample) were incubated with 4 mg of anti-Cdk2 antibody (UBI) for 2 h at 48C. Immune complexes were collected on protein A-sepharose beads, washed ®ve times with NET-N buer (Ewen et al., 1993) and twice with histone H1 kinase buer (50 mM Tris-HCl, pH 7.4, 10 mM MgCl 2 , 1 mM DTT), resuspended in 50 ml of H1 kinase buer containing ATP (10 mM), histone H1 (10 mg), and [g-32 P]ATP (10 mCi, 6000 Ci/mmol, NEN), and incubated for 30 min at 308C. Reactions were stopped by addition of 50 ml of sample buer. Samples were then boiled for 5 min and analysed by SDS ± PAGE (12% polyacrylamide). Quantitation of radiolabeled histone H1 was determined on dried gels with a Betascope Model 603 blot analyzer (Betagen Corp., Waltham, MA).
Immunoblot analysis
IEC 4-1 cells were plated and treated as described for the thymidine assay. Cells were lysed in ice-cold EBC lysis buer (50 mM Tris-HCl pH 8.0, 120 mM NaCl, 0.5% NP-40, 100 mM NaF, 200 mM Na 3 VO 4 , 100 mg/ml aprotinin, 20 mg/ ml leupeptin, 150 mM PMSF, 0.5% Na deoxycholate and 0.5% SDS) and were passed through a 21-gauge needle several times to disperse any large aggregates. Insoluble material was removed by centrifuging the cell lysates for 20 min at 48C. Protein concentrations of cell lysates were determined by the BCA protein assay (PIERCE, Rockford, IL). Proteins (70 mg per lane) were resolved by 15% SDS ± PAGE and transferred to Immobilon (Millipore, Boston, MA). Blots were stained with Ponceau S to verify equal loading, after which they were probed with 1 mg/ml of primary antibody, followed by incubation with a 1 : 5000 dilution of secondary antibody (anti-rabbit horseradish peroxidase conjugated IgG, Amersham). Proteins were visualized by enhanced chemiluminescence (ECL) according to the manufacturer's instructions (Amersham, Arlington Heights, IL).
Metabolic labeling/immunoprecipitation
IEC 4-1 cells were plated at a density of 4610 5 cells in T-75 asks in SMIGS medium. The next day, cells were washed twice with PBS to remove serum components, and were incubated in RPMI medium (Gibco BRI) medium alone for 13 h. Cells were then washed twice with PBS, and were incubated with methionine-free RPMI in the presence or absence of TGFb 3 (10 ng/ml). Cells were labeled with 100 mCi/ml of 35 S-Trans-label mix (spec. act41000 Ci/ mmol, ICN) during the last 4 h of TGFb 3 treatment. Cells were washed twice with ice-cold TBS, and were lysed with EBC lysis buer. Lysates were passed through a 21-gauge needle several times, and were clari®ed by centrifugation. Samples were normalized for radioactivity as determined by TCA precipitation. Equal radioactivity of precleared cell lysates in EBC buer were incubated with 5 mg of anti-p27 Kip1 (sc-776, Santa Cruz) for 1 ± 2 h at 48C. Immunocomplexes, collected by protein A-Sepharose, were washed ®ve times with EBC buer, and were resolved by 15% SDS ± PAGE. Gels were Coomassie-stained, soaked for 30 min in Amplify (Amersham), dried and exposed to X-ray ®lm at 7708C.
Immunoprecipitation/immunoblot
For association of CKI's with Cdk2, 300 mg precleared cell lysates in EBC buer were incubated with 10 ml anti-Cdk2 (sc-163 AC, Santa Cruz) for 1 ± 2 h at 48C. Immunocomplexes were resolved by 15% SDS ± PAGE and were transferred to immobilon (Millipore, Boston, MA). Association of CKI's with Cdk2 was detected by incubating the blots with anti-p21 Cip1 (sc-397, Santa Cruz), or anti-p27 Kip1 (K25020, Transduction Laboratories, Lexington, KY) as described above.
Induction of RasN17 protein
N17C5, N17E3, and M2N cells were each plated at a density of 6660 cells/cm 2 in 75 cm 2¯a sks. The next day, cells were rinsed twice with SM, and incubated with SM in the presence or absence of ZnCl 2 (100 mM) for 36 h to optimally induce dominant-negative mutant Ras (RasN17) protein expression (Hartsough et al., 1996) . For all studies, RasN17 expression was induced to 5 ± 6-fold above initial baseline values, which has been previously proved to decrease Ras activation by 40 ± 50% (Hartsough et al., 1996) . TGFb 3 treatment and immunoblot analysis of these cells were performed as described above.
Abbreviations
The abbreviations used are: TGFb, transforming growth factors b; Cdk, cyclin-dependent kinase; RasN17, dominant-negative Ras mutant; IECs, intestinal epithelial cells; MBP, myelin-basic protein; MAPK, mitogen-activated protein kinase; Smad's, Sma and Mad homologues; CKI's, cyclin-dependent kinase inhibitors; SDS ± PAGE, SDS-polyacrylamide gel electrophoresis; MEK, MAP and ERK kinase. SM, Supplemental McCoys 5A medium (no serum).
